Forecast & Rating4 analysts currently cover Runben Biotechnology, of which 4 give a positive rating. The average price target is ¥32.98, about 57.0% upside from the current price of ¥21.01. Coverage is limited, so the data is for reference only. Data as of Jun 11, 2026; this does not constitute investment advice.
Jun 9, 2026Price forecast
¥32.9856.97%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met50.0%
Stock price$21.01
Avg. target$34.5
High target$36
Low target$33
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.